Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2013
10/09/2013CN102432520B Preparation method for 3-[2-(dimethylamino)ethly]-N-methylindole-5-methyl sulfonylamine succinate
10/09/2013CN102351775B Preparation method of levo-5-hydroxytryptophan
10/09/2013CN102219725B Benzohetercyclic compound as well as preparation method and applications thereof
10/09/2013CN102082233B Organic compound and organic light emitting device using the same
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8552032 Bicyclic derivatives useful as inhibitors of DPP-1
10/08/2013CA2721222C Fungicidal active compound combinations
10/08/2013CA2706171C Fused indane compound
10/08/2013CA2542898C Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
10/08/2013CA2359244C .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
10/03/2013WO2013148537A1 Substituted spirobicyclic compounds and methods of use
10/03/2013WO2013147117A1 Fused azole derivative
10/03/2013WO2013146942A1 Novel compound, material for organic electroluminescence element, and organic electroluminescence element
10/03/2013WO2013146933A1 Dye-sensitized solar cell and method of manufacturing same
10/03/2013WO2013146645A1 Organic electroluminescent element
10/03/2013WO2013146437A1 3-decenoic acid derivative and use for same
10/03/2013WO2013146117A1 Material for luminescent element, and luminescent element
10/03/2013WO2013145923A1 Organic electroluminescent element
10/03/2013WO2013144101A1 Process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives
10/03/2013WO2013143481A1 Method for synthesizing and separating laropiprant and analogues thereof
10/03/2013US20130261315 Solid phase extraction method
10/03/2013US20130261130 Neurotrypsin inhibitors
10/03/2013US20130261120 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
10/03/2013US20130259830 Crth2 modulators
10/02/2013EP2643309A1 Synthesis of n-heterocycles by reductive alkylation of cyan derivatives
10/02/2013EP2643297A1 Indole derivatives as modulators of s1p receptors
10/02/2013EP2643296A1 Fluorescent cyanine-polyamine derivatives as a diagnostic probe
10/02/2013CN103339109A Tetrahydroisoquinoline derivative
10/02/2013CN103337598A Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
10/02/2013CN103333158A N-phenylcarbazole derivative and application thereof to electrophosphorescent device
10/02/2013CN103333099A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
10/02/2013CN103333098A D-tryptophan
10/02/2013CN103333097A Synthesis method of diindolylmethane derivatives
10/02/2013CN103331106A Method for extracting tryptophan by use of 1,3-bis-(2-carboxyethyl)imidazole tetrafluoroborate ionic liquid supported hydrophilic mixed cellulose liquid membrane
10/02/2013CN102351773B Synthesis method of indole type compounds
10/02/2013CN102186818B 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/01/2013US8546505 Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials
10/01/2013US8546443 Benzylic oxindole pyrimidines
10/01/2013US8546430 Thalidomide analogs
10/01/2013US8546392 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases
09/2013
09/26/2013WO2013141163A1 Compound, process for producing said compound, polymer, curable composition, and cured object
09/26/2013WO2013141014A1 Novel compound and photosensitive resin composition
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013WO2013139987A1 Chemical process for preparing spiroindolones and intermediates thereof
09/26/2013WO2013139929A1 Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
09/26/2013US20130253029 Novel bicyclic compounds
09/26/2013US20130252964 Compounds And Methods For Treating Candidiasis And Aspergillus Infections
09/26/2013US20130252955 (aza)indole derivative and use thereof for medical purposes
09/26/2013US20130251647 Low molecular weight modulators of the cold menthol receptor trpm8 and use thereof
09/26/2013US20130251637 Fluorescent compounds
09/25/2013EP2640717A1 Novel cyanine derivatives having meso-reactive functional group at polymethine chain and preparation method thereof
09/25/2013EP2640698A1 Nampt and rock inhibitors
09/25/2013CN103319397A Fullerene derivative micrometer flower and preparation method thereof
09/25/2013CN103319396A Method for preparing 1-methylindole-3-carboxylic acid
09/25/2013CN103319395A Industrialization preparation method for 4-fluoroisatin and product thereby
09/25/2013CN103319394A Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
09/25/2013CN103319393A Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
09/25/2013CN103315999A Compound amino acid composition and preparation method thereof
09/25/2013CN102617373B Amino acid modified triphenylamine organic hole transport material for all solid-state quantum dot-sensitized solar cell
09/25/2013CN102526001B Indomethacin salt transdermal patch and preparation method thereof
09/25/2013CN102249980B Process for controlling generation of 4,5-tryptophan-diketone in tryptophan
09/25/2013CN102199118B Oxo-bi(N-Methylphthalimide) synthesis method
09/24/2013US8541462 Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
09/24/2013US8541450 Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013US8541398 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
09/24/2013CA2557645C Caspase inhibitors and uses thereof
09/19/2013WO2013138600A1 Radioprotector compounds
09/19/2013WO2013137832A1 Myostatin inhibitors
09/19/2013WO2013136343A1 Amorphous saxagliptin hydrochloride
09/19/2013US20130245281 Processes for the manufacture of a pharmaceutically active agent
09/19/2013US20130245064 Novel neurotrypsin inhibitors
09/19/2013US20130245019 Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition
09/19/2013DE102013003605A1 Sekundäre Lochtransportschicht mit Tricarbazolverbindungen Secondary hole transport layer with Tricarbazolverbindungen
09/18/2013EP2639220A1 Indole derivatives and their use as antibiotics
09/18/2013EP2612850B1 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it
09/18/2013CN103313968A Nampt and rock inhibitors
09/18/2013CN103309154A Photosensitive resin composition, color filter, display device, photo-polymerization initiator and compound
09/18/2013CN103304470A Organic semiconductor material containing naphthalene, preparation method thereof and organic light-emitting device
09/18/2013CN103304469A Organic semiconductor material containing pyrene, preparation method thereof and organic light-emitting device
09/18/2013CN103304468A One-pot series synthetic method of oxoindole
09/18/2013CN103304467A Method for preparing N-coffee acyl tryptamine by one-step process
09/18/2013CN103304466A Synthetic method of 3-alkyl-substituted indole compound
09/18/2013CN103304428A Amine-based compound, organic light-emitting diode including the same, and organic light-emitting apparatus including the amine-based compound
09/18/2013CN102603619B Compound with anticancer activity and preparation method thereof
09/18/2013CN102584675B 2-bromine-3-aromatic sulfhydryl indole type compound as well as preparation method and application thereof
09/18/2013CN102558020B Method for synthesizing 3-aryl sulfydryl indole compound
09/18/2013CN102336701B Carvedilol sulphate crystals, preparation method and application thereof in medicine
09/18/2013CN101432259B Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative
09/18/2013CN101250153B Technique for preparing fluvastatin sodium crystal system
09/18/2013CN101228118B Process for the synthesis of sulfonyl halides and sulfonamides from sulfonic acid salts
09/17/2013US8536346 Process or making N-hydroxy-3[4-[[[2-(2methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor
09/17/2013US8536229 Acetylene derivatives having MGluR 5 antagonistic activity
09/17/2013US8536221 Amide derivatives as positive allosteric modulators and methods of use thereof
09/17/2013CA2669503C Compounds and methods for thiol-containing compound efflux and cancer treatment
09/17/2013CA2498644C Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
09/12/2013WO2013134467A1 Selective histone deactylase 6 inhibitors
09/12/2013WO2013134080A2 Improved method and compound for treatment of menopausal symptoms
09/12/2013WO2013133224A1 Light emitting element
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 458